Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Debt to Equity Ratio 2010-2024 | BMY

Current and historical debt to equity ratio values for Bristol Myers Squibb (BMY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bristol Myers Squibb debt/equity for the three months ending March 31, 2024 was 2.99.
  
Bristol Myers Squibb Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $82.48B $16.55B 4.98
2023-12-31 $65.67B $29.49B 2.23
2023-09-30 $62.20B $29.06B 2.14
2023-06-30 $61.46B $32.03B 1.92
2023-03-31 $62.40B $31.89B 1.96
2022-12-31 $65.70B $31.12B 2.11
2022-09-30 $65.46B $32.73B 2.00
2022-06-30 $67.70B $32.66B 2.07
2022-03-31 $71.39B $31.65B 2.26
2021-12-31 $73.31B $36.01B 2.04
2021-09-30 $73.61B $37.28B 1.97
2021-06-30 $73.92B $36.87B 2.01
2021-03-31 $74.76B $37.67B 1.98
2020-12-31 $80.60B $37.88B 2.13
2020-09-30 $75.31B $50.23B 1.50
2020-06-30 $78.92B $49.16B 1.61
2020-03-31 $79.31B $49.98B 1.59
2019-12-31 $78.25B $51.70B 1.51
2019-09-30 $39.68B $17.75B 2.24
2019-06-30 $39.01B $16.15B 2.42
2019-03-31 $19.52B $15.32B 1.27
2018-12-31 $20.86B $14.13B 1.48
2018-09-30 $19.98B $13.75B 1.45
2018-06-30 $20.22B $12.42B 1.63
2018-03-31 $20.18B $12.91B 1.56
2017-12-31 $21.70B $11.85B 1.83
2017-09-30 $19.06B $14.91B 1.28
2017-06-30 $18.59B $14.82B 1.25
2017-03-31 $18.40B $14.54B 1.27
2016-12-31 $17.36B $16.35B 1.06
2016-09-30 $17.95B $15.78B 1.14
2016-06-30 $17.75B $15.08B 1.18
2016-03-31 $17.34B $14.55B 1.19
2015-12-31 $17.32B $14.42B 1.20
2015-09-30 $16.51B $15.27B 1.08
2015-06-30 $16.66B $15.29B 1.09
2015-03-31 $17.89B $15.69B 1.14
2014-12-31 $18.77B $14.98B 1.25
2014-09-30 $18.25B $15.20B 1.20
2014-06-30 $18.12B $15.38B 1.18
2014-03-31 $17.89B $15.53B 1.15
2013-12-31 $23.36B $15.24B 1.53
2013-09-30 $22.09B $14.71B 1.50
2013-06-30 $21.88B $14.37B 1.52
2013-03-31 $22.26B $13.70B 1.63
2012-12-31 $22.26B $13.64B 1.63
2012-09-30 $22.14B $13.90B 1.59
2012-06-30 $15.86B $15.81B 1.00
2012-03-31 $16.16B $16.25B 1.00
2011-12-31 $17.10B $15.87B 1.08
2011-09-30 $15.58B $16.44B 0.95
2011-06-30 $15.69B $16.15B 0.97
2011-03-31 $14.95B $15.90B 0.94
2010-12-31 $15.44B $15.64B 0.99
2010-09-30 $16.03B $15.86B 1.01
2010-06-30 $15.48B $15.57B 0.99
2010-03-31 $15.52B $15.23B 1.02
2009-12-31 $16.22B $14.79B 1.10
2009-09-30 $16.58B $14.37B 1.15
2009-06-30 $15.87B $13.94B 1.14
2009-03-31 $16.56B $13.13B 1.26
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $81.206B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $165.962B 16.61
Vertex Pharmaceuticals (VRTX) United States $121.357B 31.23
Regeneron Pharmaceuticals (REGN) United States $112.840B 27.60
CSL (CSLLY) Australia $96.825B 0.00
Gilead Sciences (GILD) United States $82.961B 16.52
GSK (GSK) United Kingdom $79.708B 9.52
Moderna (MRNA) United States $44.437B 0.00
Biogen (BIIB) United States $32.703B 14.97
Alnylam Pharmaceuticals (ALNY) United States $31.456B 0.00
Argenex SE (ARGX) Netherlands $25.870B 0.00
BioNTech SE (BNTX) Germany $18.985B 159.72
Illumina (ILMN) United States $16.771B 119.64
Genmab (GMAB) Denmark $16.632B 19.50
BioMarin Pharmaceutical (BMRN) United States $15.376B 59.98
Sarepta Therapeutics (SRPT) United States $14.473B 1275.92
BeiGene (BGNE) Cayman Islands $14.280B 0.00
Incyte (INCY) United States $12.947B 20.02
Bio-Techne Corp (TECH) United States $11.259B 42.53
QIAGEN (QGEN) Netherlands $9.260B 19.78
Insmed (INSM) United States $9.213B 0.00
Legend Biotech (LEGN) United States $8.369B 0.00
Vaxcyte (PCVX) United States $8.297B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.085B 26.44
Exact Sciences (EXAS) United States $7.970B 0.00
Ascendis Pharma (ASND) Denmark $7.814B 0.00
Roivant Sciences (ROIV) United Kingdom $7.742B 0.00
Intra-Cellular Therapies (ITCI) United States $7.292B 0.00
Blueprint Medicines (BPMC) United States $6.827B 0.00
Repligen (RGEN) United States $6.748B 88.15
Exelixis (EXEL) United States $6.658B 34.31
Zealand Pharma (ZLDPF) Denmark $6.635B 0.00
Halozyme Therapeutics (HALO) United States $6.620B 18.38
Cytokinetics (CYTK) United States $5.704B 0.00
Viking Therapeutics (VKTX) United States $5.565B 0.00
Krystal Biotech (KRYS) United States $5.071B 0.00
Nuvalent (NUVL) United States $4.651B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.577B 0.00
ImmunityBio (IBRX) United States $4.343B 0.00
Apellis Pharmaceuticals (APLS) United States $4.298B 0.00
Alkermes (ALKS) Ireland $4.100B 16.05
Immunovant (IMVT) United States $3.830B 0.00
Axsome Therapeutics (AXSM) United States $3.810B 0.00
Avidity Biosciences (RNA) United States $3.559B 0.00
Guardant Health (GH) United States $3.477B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.343B 0.00
Merus (MRUS) Netherlands $3.108B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.053B 0.00
Denali Therapeutics (DNLI) United States $3.038B 0.00
Biohaven (BHVN) United States $2.983B 0.00
Arcellx (ACLX) United States $2.928B 0.00
Amicus Therapeutics (FOLD) United States $2.906B 0.00
Twist Bioscience (TWST) United States $2.795B 0.00
SpringWorks Therapeutics (SWTX) United States $2.762B 0.00
MorphoSys AG (MOR) Germany $2.741B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.726B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.696B 0.00
ADMA Biologics Inc (ADMA) United States $2.599B 101.91
Geron (GERN) United States $2.586B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.576B 0.00
IDEAYA Biosciences (IDYA) United States $2.520B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.488B 0.00
Celldex Therapeutics (CLDX) United States $2.367B 0.00
Myriad Genetics (MYGN) United States $2.258B 0.00
Certara (CERT) United States $2.226B 51.26
Intellia Therapeutics (NTLA) United States $2.214B 0.00
Apogee Therapeutics (APGE) United States $2.192B 0.00
Vericel (VCEL) United States $2.183B 0.00
Fortrea Holdings (FTRE) United States $2.098B 25.79
Iovance Biotherapeutics (IOVA) United States $2.068B 0.00
CG Oncology (CGON) United States $2.055B 0.00
Protagonist Therapeutics (PTGX) United States $2.024B 14.14
Janux Therapeutics (JANX) United States $1.996B 0.00
Bavarian Nordic (BVNRY) Denmark $1.976B 8.60
Beam Therapeutics (BEAM) United States $1.933B 0.00
Vera Therapeutics (VERA) United States $1.909B 0.00
Kymera Therapeutics (KYMR) United States $1.851B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.818B 0.00
NovoCure (NVCR) Jersey $1.815B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.801B 0.00
Novavax (NVAX) United States $1.762B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.754B 13.37
NeoGenomics (NEO) United States $1.753B 0.00
Structure Therapeutics (GPCR) United States $1.746B 0.00
Zai Lab (ZLAB) China $1.708B 0.00
Edgewise Therapeutics (EWTX) United States $1.707B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.707B 0.00
Galapagos (GLPG) Belgium $1.640B 0.00
Arvinas (ARVN) United States $1.636B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.597B 0.00
Morphic Holding (MORF) United States $1.594B 0.00
Neumora Therapeutics (NMRA) United States $1.557B 0.00
Kura Oncology (KURA) United States $1.528B 0.00
Keros Therapeutics (KROS) United States $1.522B 0.00
Akero Therapeutics (AKRO) United States $1.516B 0.00
Ligand Pharmaceuticals (LGND) United States $1.489B 24.32
Dynavax Technologies (DVAX) United States $1.442B 183.67
MannKind (MNKD) United States $1.370B 167.67
Belite Bio (BLTE) United States $1.363B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.355B 0.00
Arcus Biosciences (RCUS) United States $1.306B 0.00
ANI Pharmaceuticals (ANIP) United States $1.276B 15.84
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.270B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.241B 0.00
Vir Biotechnology (VIR) United States $1.192B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.180B 0.00
Sana Biotechnology (SANA) United States $1.156B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.111B 0.00
Disc Medicine (IRON) United States $1.098B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.093B 0.00
Prothena (PRTA) Ireland $1.079B 0.00
Spyre Therapeutics (SYRE) United States $1.038B 0.00
MiMedx (MDXG) United States $1.007B 42.62
Gyre Therapeutics (GYRE) United States $1.002B 0.00
Immatics (IMTX) Germany $1.001B 0.00
Cullinan Therapeutics (CGEM) United States $0.967B 0.00
Nurix Therapeutics (NRIX) United States $0.954B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.928B 0.00
Liquidia Technologies (LQDA) United States $0.914B 0.00
Tyra Biosciences (TYRA) United States $0.892B 0.00
Tango Therapeutics (TNGX) United States $0.891B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.838B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.830B 0.00
Rapport Therapeutics (RAPP) $0.824B 0.00
Abivax SA (ABVX) France $0.822B 0.00
Cogent Biosciences (COGT) United States $0.799B 0.00
AbCellera Biologics (ABCL) Canada $0.797B 0.00
Viridian Therapeutics (VRDN) United States $0.782B 0.00
Mesoblast (MESO) Australia $0.777B 0.00
Dianthus Therapeutics (DNTH) United States $0.776B 0.00
89BIO (ETNB) United States $0.736B 0.00
Cytek Biosciences (CTKB) United States $0.731B 0.00
Immunome (IMNM) United States $0.727B 0.00
Nuvation Bio (NUVB) United States $0.724B 0.00
CARGO Therapeutics (CRGX) United States $0.704B 0.00
Tectonic Therapeutic (TECX) United States $0.704B 0.00
HilleVax (HLVX) United States $0.701B 0.00
CureVac (CVAC) Germany $0.699B 0.00
Praxis Precision Medicines (PRAX) United States $0.684B 0.00
AnaptysBio (ANAB) United States $0.680B 0.00
Humacyte (HUMA) United States $0.675B 0.00
Stoke Therapeutics (STOK) United States $0.660B 0.00
WAVE Life Sciences (WVE) Singapore $0.652B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Prime Medicine (PRME) United States $0.641B 0.00
Pliant Therapeutics (PLRX) United States $0.638B 0.00
GH Research (GHRS) Ireland $0.627B 0.00
PureTech Health (PRTC) United States $0.626B 0.00
Scholar Rock Holding (SRRK) United States $0.620B 0.00
ArriVent BioPharma (AVBP) United States $0.612B 0.00
Travere Therapeutics (TVTX) United States $0.604B 0.00
Mineralys Therapeutics (MLYS) United States $0.603B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.600B 0.00
Olema Pharmaceuticals (OLMA) United States $0.597B 0.00
Arbutus Biopharma (ABUS) United States $0.596B 0.00
Zymeworks (ZYME) United States $0.593B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.591B 0.00
Castle Biosciences (CSTL) United States $0.587B 0.00
Celcuity (CELC) United States $0.573B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
Pharming Group (PHAR) Netherlands $0.568B 0.00
PepGen (PEPG) United States $0.541B 0.00
ITeos Therapeutics (ITOS) United States $0.534B 0.00
REGENXBIO (RGNX) United States $0.533B 0.00
Pharming Group (PHGUF) Netherlands $0.526B 0.00
Contineum Therapeutics (CTNM) United States $0.517B 0.00
Northwest Biotherapeutics (NWBO) United States $0.513B 0.00
Oric Pharmaceuticals (ORIC) United States $0.507B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.504B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.502B 0.00
Applied Therapeutics (APLT) United States $0.500B 0.00
Adaptive Biotechnologies (ADPT) United States $0.500B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.499B 0.00
Replimune (REPL) United States $0.497B 0.00
Astria Therapeutics (ATXS) United States $0.494B 0.00
Avid Bioservices (CDMO) United States $0.490B 0.00
Third Harmonic Bio (THRD) United States $0.489B 0.00
Entrada Therapeutics (TRDA) United States $0.479B 22.52
Oculis Holding AG (OCS) Switzerland $0.475B 0.00
Neurogene (NGNE) United States $0.467B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.449B 0.00
Terns Pharmaceuticals (TERN) United States $0.444B 0.00
Annexon (ANNX) United States $0.443B 0.00
Allogene Therapeutics (ALLO) United States $0.435B 0.00
Alector (ALEC) United States $0.425B 0.00
Ocugen (OCGN) United States $0.422B 0.00
Voyager Therapeutics (VYGR) United States $0.420B 0.00
ACELYRIN, INC (SLRN) United States $0.411B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.409B 0.00
EnGene Holdings (ENGN) United States $0.397B 0.00
Emergent Biosolutions (EBS) United States $0.395B 0.00
MaxCyte (MXCT) United States $0.394B 0.00
Editas Medicine (EDIT) United States $0.383B 0.00
Fulcrum Therapeutics (FULC) United States $0.383B 0.00
IGM Biosciences (IGMS) United States $0.381B 0.00
Erasca (ERAS) United States $0.378B 0.00
AC Immune (ACIU) Switzerland $0.377B 0.00
Precigen (PGEN) United States $0.371B 0.00
Anika Therapeutics (ANIK) United States $0.370B 317.00
Cabaletta Bio (CABA) United States $0.364B 0.00
Fate Therapeutics (FATE) United States $0.360B 0.00
Absci (ABSI) United States $0.360B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.358B 0.00
Urogen Pharma (URGN) United States $0.352B 0.00
Anavex Life Sciences (AVXL) United States $0.349B 0.00
Aura Biosciences (AURA) United States $0.342B 0.00
Jasper Therapeutics (JSPR) United States $0.335B 0.00
Kyverna Therapeutics (KYTX) United States $0.331B 0.00
Scilex Holding (SCLX) United States $0.326B 0.00
Cartesian Therapeutics (RNAC) United States $0.314B 0.00
C4 Therapeutics (CCCC) United States $0.313B 0.00
Alto Neuroscience (ANRO) United States $0.312B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.312B 0.00
TScan Therapeutics (TCRX) United States $0.310B 0.00
Agenus (AGEN) United States $0.305B 0.00
XOMA (XOMA) United States $0.301B 0.00
Kamada (KMDA) Israel $0.296B 22.39
ALX Oncology Holdings (ALXO) United States $0.292B 0.00
Alimera Sciences (ALIM) United States $0.289B 0.00
Poseida Therapeutics (PSTX) United States $0.285B 0.00
Nautilus Biotechnology (NAUT) United States $0.284B 0.00
Amarin (AMRN) Ireland $0.282B 0.00
Revance Therapeutics (RVNC) United States $0.280B 0.00
Inozyme Pharma (INZY) United States $0.278B 0.00
Atea Pharmaceuticals (AVIR) United States $0.276B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.271B 0.00
Nkarta (NKTX) United States $0.265B 0.00
MeiraGTx Holdings (MGTX) United States $0.259B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.253B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.252B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.247B 0.00
Molecular Partners AG (MOLN) Switzerland $0.243B 0.00
Sutro Biopharma (STRO) United States $0.236B 0.00
Renovaro (RENB) United States $0.233B 0.00
Gossamer Bio (GOSS) United States $0.233B 0.00
Solid Biosciences (SLDB) United States $0.229B 0.00
Tenaya Therapeutics (TNYA) United States $0.228B 0.00
CorMedix Inc (CRMD) United States $0.227B 0.00
Mersana Therapeutics (MRSN) United States $0.225B 0.00
Inovio Pharmaceuticals (INO) United States $0.216B 0.00
Greenwich LifeSciences (GLSI) United States $0.215B 0.00
Skye Bioscience (SKYE) United States $0.209B 0.00
23andMe Holding (ME) United States $0.208B 0.00
Q32 Bio (QTTB) United States $0.207B 0.00
2seventy Bio (TSVT) United States $0.206B 0.00
Codexis (CDXS) United States $0.203B 0.00
GENFIT S.A (GNFT) France $0.198B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.196B 0.00
Inhibrx Biosciences (INBX) $0.195B 0.00
ChromaDex (CDXC) United States $0.192B 0.00
UniQure (QURE) Netherlands $0.190B 0.00
Rani Therapeutics Holdings (RANI) United States $0.190B 0.00
Trevi Therapeutics (TRVI) United States $0.188B 0.00
Candel Therapeutics (CADL) United States $0.188B 0.00
Design Therapeutics (DSGN) United States $0.180B 0.00
Abeona Therapeutics (ABEO) United States $0.178B 0.00
XBiotech (XBIT) United States $0.176B 0.00
Shattuck Labs (STTK) United States $0.176B 0.00
Prima BioMed (IMMP) Australia $0.174B 0.00
Innate Pharma S.A (IPHA) France $0.174B 0.00
Adocia (ADOCY) France $0.174B 0.00
Rezolute (RZLT) United States $0.167B 0.00
Oncobiologics (OTLK) United States $0.166B 0.00
Adherex Technologies (FENC) United States $0.165B 201.00
Generation Bio (GBIO) United States $0.162B 0.00
Coherus BioSciences (CHRS) United States $0.159B 0.00
INmune Bio (INMB) United States $0.158B 0.00
Ventyx Biosciences (VTYX) United States $0.157B 0.00
Biomea Fusion (BMEA) United States $0.156B 0.00
Inventiva S.A (IVA) France $0.156B 0.00
BioStem Technologies (BSEM) $0.155B 0.00
ScPharmaceuticals (SCPH) United States $0.153B 0.00
Zura Bio (ZURA) United States $0.153B 0.00
Lifecore Biomedical (LFCR) United States $0.149B 0.00
Vigil Neuroscience (VIGL) United States $0.148B 0.00
Adverum Biotechnologies (ADVM) United States $0.148B 0.00
Elevation Oncology (ELEV) United States $0.148B 0.00
Puma Biotechnology (PBYI) United States $0.146B 9.15
Compugen (CGEN) Israel $0.145B 0.00
Caribou Biosciences (CRBU) United States $0.145B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.142B 0.00
FibroBiologics (FBLG) United States $0.138B 0.00
Repare Therapeutics (RPTX) Canada $0.135B 0.00
G1 Therapeutics (GTHX) United States $0.134B 0.00
Adlai Nortye (ANL) Cayman Islands $0.134B 0.00
Syros Pharmaceuticals (SYRS) United States $0.134B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.133B 0.00
Invivyd (IVVD) United States $0.131B 0.00
Adagene (ADAG) China $0.128B 0.00
I-Mab (IMAB) China $0.121B 0.00
Kodiak Sciences (KOD) United States $0.116B 0.00
Cellectis S.A (CLLS) France $0.114B 0.00
Semper Paratus Acquisition (TVGN) United States $0.114B 0.00
Nuvectis Pharma (NVCT) United States $0.114B 0.00
Compass Therapeutics (CMPX) United States $0.113B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.111B 0.00
PDS Biotechnology (PDSB) United States $0.110B 0.00
Opthea (OPT) Australia $0.110B 0.00
DiaMedica Therapeutics (DMAC) United States $0.110B 0.00
TELA Bio (TELA) United States $0.107B 0.00
Elutia (ELUT) United States $0.106B 0.00
Seres Therapeutics (MCRB) United States $0.106B 0.00
ATyr Pharma (ATYR) United States $0.106B 0.00
Seer (SEER) United States $0.106B 0.00
Akoya Biosciences (AKYA) United States $0.105B 0.00
Omega Therapeutics (OMGA) United States $0.104B 0.00
Immunic (IMUX) United States $0.103B 0.00
CytomX Therapeutics (CTMX) United States $0.101B 6.50
Cardiff Oncology (CRDF) United States $0.101B 0.00
Bluebird Bio (BLUE) United States $0.100B 0.00
Athira Pharma (ATHA) United States $0.099B 0.00
CervoMed (CRVO) United States $0.098B 0.00
BeyondSpring (BYSI) United States $0.096B 0.00
InflaRx (IFRX) Germany $0.096B 0.00
Rapt Therapeutics (RAPT) United States $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.095B 0.00
X4 Pharmaceuticals (XFOR) United States $0.095B 0.00
Boundless Bio (BOLD) United States $0.094B 0.00
Werewolf Therapeutics (HOWL) United States $0.093B 0.00
Annovis Bio (ANVS) United States $0.090B 0.00
Adicet Bio (ACET) United States $0.090B 0.00
VistaGen Therapeutics (VTGN) United States $0.089B 0.00
Coya Therapeutics (COYA) United States $0.087B 0.00
Sagimet Biosciences (SGMT) United States $0.087B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.085B 0.00
Eton Pharmaceuticals (ETON) United States $0.085B 82.25
Benitec Biopharma (BNTC) United States $0.083B 0.00
AN2 Therapeutics (ANTX) United States $0.081B 0.00
Earth Science Tech (ETST) United States $0.080B 0.00
Ikena Oncology (IKNA) United States $0.079B 0.00
Chimerix (CMRX) United States $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
Affimed (AFMD) Germany $0.078B 0.00
Oncolytics Biotech (ONCY) Canada $0.077B 0.00
Verastem (VSTM) United States $0.074B 0.00
IO Biotech (IOBT) Denmark $0.074B 0.00
Connect Biopharma Holdings (CNTB) United States $0.074B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.073B 0.00
China Health Industries Holdings (CHHE) China $0.072B 0.00
DBV Technologies S.A (DBVT) France $0.072B 0.00
Spero Therapeutics (SPRO) United States $0.072B 2.60
Cognition Therapeutics (CGTX) United States $0.071B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.071B 0.00
BioAtla (BCAB) United States $0.069B 0.00
MediciNova (MNOV) United States $0.069B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.068B 0.00
Kronos Bio (KRON) United States $0.068B 0.00
Allakos (ALLK) United States $0.067B 0.00
Sangamo Therapeutics (SGMO) United States $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.067B 0.00
Instil Bio (TIL) United States $0.066B 0.00
Genelux (GNLX) United States $0.066B 0.00
Galena Biopharma (SLS) United States $0.066B 0.00
Immix Biopharma (IMMX) United States $0.065B 0.00
LENZ Therapeutics (LENZ) United States $0.064B 0.00
Precision BioSciences (DTIL) United States $0.064B 0.00
Vor Biopharma (VOR) $0.063B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.062B 0.00
Theratechnologies (THTX) Canada $0.062B 0.00
Gritstone Bio (GRTS) United States $0.062B 0.00
Aileron Therapeutics (ALRN) United States $0.061B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.061B 0.00
Celularity (CELU) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
HOOKIPA Pharma (HOOK) United States $0.057B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.057B 0.00
Genenta Science S.p.A (GNTA) Italy $0.056B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.056B 0.00
Cidara Therapeutics (CDTX) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.055B 0.00
VTv Therapeutics (VTVT) United States $0.055B 0.00
Passage Bio (PASG) United States $0.055B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.053B 0.00
Ovid Therapeutics (OVID) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.053B 0.00
Rallybio (RLYB) United States $0.053B 0.00
LakeShore Biopharma (LSB) China $0.053B 0.00
Turnstone Biologics (TSBX) United States $0.052B 0.00
ARCA Biopharma (ABIO) United States $0.050B 0.00
Alpha Teknova (TKNO) United States $0.049B 0.00
Aerovate Therapeutics (AVTE) United States $0.049B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Leap Therapeutics (LPTX) United States $0.047B 0.00
Lantern Pharma (LTRN) United States $0.046B 0.00
CalciMedica (CALC) United States $0.046B 0.00
NextCure (NXTC) United States $0.044B 0.00
Dyadic (DYAI) United States $0.043B 0.00
Kezar Life Sciences (KZR) United States $0.042B 0.00
Clene (CLNN) United States $0.042B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.042B 0.00
Estrella Immunopharma (ESLA) United States $0.042B 0.00
Eyenovia (EYEN) United States $0.041B 0.00
Ocuphire Pharma (OCUP) United States $0.041B 0.00
BioXcel Therapeutics (BTAI) United States $0.041B 0.00
Bionano Genomics (BNGO) United States $0.038B 0.00
Ocean Biomedical (OCEA) United States $0.038B 0.00
Elicio Therapeutics (ELTX) United States $0.038B 0.00
Atara Biotherapeutics (ATRA) United States $0.037B 0.00
Curis (CRIS) United States $0.037B 0.00
Carmell (CTCX) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.036B 0.00
IN8bio (INAB) United States $0.035B 0.00
Cyclo Therapeutics (CYTH) United States $0.035B 0.00
Aadi Bioscience (AADI) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.034B 0.00
OKYO Pharma (OKYO) $0.034B 0.00
Immuneering (IMRX) United States $0.034B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.033B 0.00
Aligos Therapeutics (ALGS) United States $0.033B 0.00
NKGen Biotech (NKGN) United States $0.033B 0.00
Xilio Therapeutics (XLO) United States $0.032B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Quince Therapeutics (QNCX) United States $0.030B 0.00
Lisata Therapeutics (LSTA) United States $0.028B 0.00
Bolt Biotherapeutics (BOLT) United States $0.028B 0.00
Beyond Air (XAIR) United States $0.027B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
RenovoRx (RNXT) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
BioAffinity Technologies (BIAF) United States $0.025B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
Femasys (FEMY) United States $0.024B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.024B 0.00
HCW Biologics (HCWB) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.023B 0.00
Equillium (EQ) United States $0.023B 0.00
Spruce Biosciences (SPRB) United States $0.023B 0.00
Biora Therapeutics (BIOR) United States $0.023B 0.00
Orgenesis (ORGS) United States $0.022B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
Vincerx Pharma (VINC) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
UNITY Biotechnology (UBX) United States $0.022B 0.00
VBI Vaccines (VBIV) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.020B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Forte Biosciences (FBRX) United States $0.019B 0.00
BRIACELL THERAP (BCTX) Canada $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Lumos Pharma (LUMO) United States $0.018B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Evaxion Biotech (EVAX) Denmark $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
Apollomics (APLM) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Sensei Biotherapeutics (SNSE) United States $0.016B 0.00
Kintara Therapeutics (KTRA) United States $0.015B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Senti Biosciences (SNTI) United States $0.015B 0.00
Aptose Biosciences (APTO) Canada $0.014B 0.00
Galecto (GLTO) Denmark $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
Monopar Therapeutics (MNPR) United States $0.012B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.011B 0.00
Chemomab Therapeutics (CMMB) Israel $0.011B 0.00
Longeveron (LGVN) United States $0.010B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Eterna Therapeutics (ERNA) United States $0.010B 0.00
Purple Biotech (PPBT) Israel $0.009B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
AEterna Zentaris (AEZS) Canada $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
NuCana (NCNA) United Kingdom $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
GeoVax Labs (GOVX) United States $0.007B 0.00
Telesis Bio (TBIO) United States $0.006B 0.00
AquaBounty Technologies (AQB) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Genetic Technologies (GENE) Australia $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Notable Labs (NTBL) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Biofrontera (BFRI) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Trevena (TRVN) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Novogen (KZIA) Australia $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
NexImmune (NEXI) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Portage Biotech (PRTG) $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Psyence Biomedical (PBM) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Cingulate (CING) United States $0.002B 0.00
Soligenix (SNGX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.001B 0.00
CNS Pharmaceuticals (CNSP) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00